Skip to content

JNJ vs XOM: Dividend Comparison

JNJ$278.81
Johnson & Johnson
Health Care
vs
XOM$167.37
Exxon Mobil Corp
Energy

Dividend data as of

Johnson & Johnson (JNJ) from Health Care and Exxon Mobil Corp (XOM) from Energy offer different dividend profiles for income-focused portfolios. XOM edges ahead on yield at 2.56% versus JNJ's 1.90%. For dividend growth, JNJ leads with a 5-year CAGR of 5.0% versus XOM's 3.6%. XOM holds the edge in dividend safety with a "Safe" rating. JNJ is a Dividend King while XOM is a Dividend Aristocrat.

Verdict

Best for Income
XOM
Higher yield at 2.56%
Best for Growth
JNJ
5yr CAGR of 5.0%
Best for Safety
XOM
Rated "Safe"

Track JNJ and XOM in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan (1 portfolio, 10 holdings).

30-day free brokerage sync trial. No credit card. Then from $9.99/month. Choosing a tracker? See the best dividend trackers compared.

Metric
Price
$278.81
$167.37
Dividend Yield
1.90%
2.56%
Annual Dividend
$5.36
$4.28
5yr Div CAGR
5.0%
3.6%
3yr Div CAGR
4.4%
4.2%
Consecutive Years
61
43
Payout Ratio
80.12%
42.39%
P/E Ratio
—
—
Market Cap
—
—
Income on $10k
$190/yr
$256/yr

Yield Analysis

JNJ
1.90%
XOM
2.56%

XOM yields 0.67% more than JNJ. In dollar terms, JNJ pays $5.36/share vs XOM's $4.28/share annually.

Dividend Growth

JNJ 5yr CAGR
5.0%
decelerating
XOM 5yr CAGR
3.6%
accelerating

JNJ: Dividend growth is slowing — the 3-year CAGR of 4.4% trails the 5-year rate of 5.0% and the 10-year rate of 5.3%.

XOM: Dividend growth is accelerating — the 3-year CAGR of 4.2% exceeds the 5-year rate of 3.6% and the 10-year rate of 3.4%.

Dividend Safety

JNJ
At Risk
Payout Ratio80%
XOM
Safe
Payout Ratio42%

JNJ: The payout ratio of 80% is elevated, which may indicate the dividend could be cut if earnings decline. Earnings cover the dividend 1.2x.

XOM: The payout ratio of 42% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 2.2x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
JNJ
XOM
$10,000
$190/yr
$256/yr
$50,000
$949/yr
$1,282/yr
$100,000
$1,897/yr
$2,565/yr

What does $10,000 buy in JNJ vs XOM today?

At $278.81 per share, $10,000 buys about 35.9 shares of Johnson & Johnson (JNJ). Each share pays $5.36 per year in dividends, so the position starts out generating roughly $192 per year — about $16 a month.

At $167.37 per share, $10,000 buys about 59.7 shares of Exxon Mobil Corp (XOM). Each share pays $4.28 per year in dividends, so the position starts out generating roughly $256 per year — about $21 a month.

XOM is the larger income stream from day one: $63 per year more on the same $10,000 invested.

What could $10,000 of JNJ or XOM income look like in 10 years?

Johnson & Johnson (JNJ) has raised its dividend about 5.0% a year over the past five years. If that pace held, the $190 per year that $10,000 generates today at the current 1.90% yield would reach $308 per year by 2036 — a 3.1% yield on the original cost.

Exxon Mobil Corp (XOM) has raised its dividend about 3.6% a year over the past five years. If that pace held, the $256 per year that $10,000 generates today at the current 2.56% yield would reach $364 per year by 2036 — a 3.6% yield on the original cost.

On those trailing rates, XOM pays more in 2036: $364 versus $308 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would JNJ's dividend growth overtake XOM's higher yield?

Johnson & Johnson (JNJ) yields less today (1.90% vs 2.56%) but has grown its dividend faster — 5.0% vs 3.6% a year over the past five years. If both trends continued, a $10,000 position in JNJ would start out-earning the same position in XOM around 2049 (roughly 23 years from now), paying about $580 per year at the crossover. Before that point, XOM pays more each year; after it, the gap compounds in JNJ's favor.

Can JNJ and XOM afford their dividends?

Johnson & Johnson (JNJ) earns $6.59 per share against $5.36 paid out in dividends — 1.2x coverage (a 80% payout ratio).

Exxon Mobil Corp (XOM) earns $9.51 per share against $4.28 paid out in dividends — 2.2x coverage (a 42% payout ratio).

XOM's wider coverage leaves more cushion if earnings dip. As a rule of thumb, coverage below about 1.5x (a payout ratio above ~65%) is where a dividend starts to look stretched — worth watching for JNJ if earnings weaken.

Which fits an early-retirement income portfolio better, JNJ or XOM?

For income you need right now, Exxon Mobil Corp (XOM) leads: $100,000 invested today pays about $214 a month at the current 2.56% yield, versus $158 a month from Johnson & Johnson (JNJ) at 1.90%.

With a decade or more before the income is needed, JNJ's faster dividend growth (5.0% vs 3.6% a year) matters more than the starting yield — raises compound into the larger paycheck over time.

On consistency: JNJ has raised its dividend 61 consecutive years; XOM has raised its dividend 43 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $372/yr in JNJ vs $469/yr in XOM by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.